UY27472A1 - METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ACID-5-AMINO-SALICILICO, FOR USE IN THE TREATMENT OF ULCEROUS COLITIS AND DISEASE OF CROHN. - Google Patents

METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ACID-5-AMINO-SALICILICO, FOR USE IN THE TREATMENT OF ULCEROUS COLITIS AND DISEASE OF CROHN.

Info

Publication number
UY27472A1
UY27472A1 UY27472A UY27472A UY27472A1 UY 27472 A1 UY27472 A1 UY 27472A1 UY 27472 A UY27472 A UY 27472A UY 27472 A UY27472 A UY 27472A UY 27472 A1 UY27472 A1 UY 27472A1
Authority
UY
Uruguay
Prior art keywords
acid
crohn
disease
treatment
pharmaceutical composition
Prior art date
Application number
UY27472A
Other languages
Spanish (es)
Inventor
Svenn Kluver Jepsen
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Priority to UY27472A priority Critical patent/UY27472A1/en
Publication of UY27472A1 publication Critical patent/UY27472A1/en

Links

Abstract

La presente invención se refiere a un nuevo método para preparar gránulos que comprende un ácido 5-aminosalicílico y un nuevo método para preparar una composición farmacéutica para el tratamiento de colitis ulcerosa o enfermedad de Crohn mediante la administración oral que comprende como ingrediente activo ácido 5-aminosalicílico.The present invention relates to a new method for preparing granules comprising a 5-aminosalicylic acid and a new method for preparing a pharmaceutical composition for the treatment of ulcerative colitis or Crohn's disease by oral administration comprising as active ingredient acid 5- aminosalicylic.

UY27472A 2002-10-04 2002-10-04 METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ACID-5-AMINO-SALICILICO, FOR USE IN THE TREATMENT OF ULCEROUS COLITIS AND DISEASE OF CROHN. UY27472A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27472A UY27472A1 (en) 2002-10-04 2002-10-04 METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ACID-5-AMINO-SALICILICO, FOR USE IN THE TREATMENT OF ULCEROUS COLITIS AND DISEASE OF CROHN.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27472A UY27472A1 (en) 2002-10-04 2002-10-04 METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ACID-5-AMINO-SALICILICO, FOR USE IN THE TREATMENT OF ULCEROUS COLITIS AND DISEASE OF CROHN.

Publications (1)

Publication Number Publication Date
UY27472A1 true UY27472A1 (en) 2003-05-30

Family

ID=38812693

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27472A UY27472A1 (en) 2002-10-04 2002-10-04 METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ACID-5-AMINO-SALICILICO, FOR USE IN THE TREATMENT OF ULCEROUS COLITIS AND DISEASE OF CROHN.

Country Status (1)

Country Link
UY (1) UY27472A1 (en)

Similar Documents

Publication Publication Date Title
EA200700049A1 (en) PREPARATIVE FORMS OF ORAL MEDICINAL FORMS OF MEMANTINE WITH MODIFIED SURVIVAL
ATE418324T1 (en) MUCOADHESIVE FORMULATION CONTAINING XYLOGLUCAN FOR MEDICAL DEVICES AND PHARMACEUTICAL DOSAGE FORMS
BRPI0508579A (en) compound, pharmaceutical composition, and use of a compound
AR048431A1 (en) GALENIC FORMULATIONS OF ORGANIC COMPOUNDS
MY143795A (en) Tetrahydropyridoindole derivatives
ATE493973T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN
DE602006014990D1 (en) INTRANASAL ADMINISTRATION OF FAST-ACTING INSULIN
NO20043871L (en) Controlled release drug formulations containing a carrier peptide
NO20080827L (en) Solid dosage formulations of narcotic drugs that have improved buccal adsorption
CO5640120A2 (en) FORMULATION AND METHODS FOR THE TROMBOCITEMIA TREATMENT
RS54050B1 (en) Formulations and methods for treating amyloidosis
MX2012000275A (en) Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement.
NZ605469A (en) Nalbuphine-based formulations and uses thereof
BRPI0415953A (en) oral controlled release dosage formulation, method of treating a disorder, set of controlled release dosage forms and method for administering the formulation
AR044200A1 (en) COMPOSITION OF FONDAPARINUX SODICO DE HIGH PURITY, A PROCEDURE FOR THE PREPARATION OF THIS COMPOSITION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT AS AN ACTIVE PRINCIPLE
UA96622C2 (en) Solid dosage forms comprising aliskiren obtained by solvent-free granulation process
NO20034863L (en) Deuterated 3-piperidinopropiophenone as well as drugs containing these compounds
CL2009001267A1 (en) Compounds derived from nitrogenous tricycles, with antibacterial activity; preparation procedure; pharmaceutical composition comprising them; for the treatment of tuberculosis.
ATE347358T1 (en) FLOATING ORAL FORMULATIONS WITH CONTROLLED RELEASE OF BETAIN
BRPI0506630A (en) controlled release composition and method for administering a controlled release transmucosal aqueous drug
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
MXPA04003506A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease.
UA93365C2 (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts, and processes for the preparation thereof
RU2006131594A (en) 5-AMINOSALICYLIC ACID GLYCOSIDE PROCEDURE
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150415

RDES Application refused

Effective date: 20190228